Overcoming the barriers to xenotransplantation: prospects for the future
- 1 March 2010
- journal article
- research article
- Published by Informa UK Limited in Expert Review of Clinical Immunology
- Vol. 6 (2), 219-230
- https://doi.org/10.1586/eci.09.81
Abstract
Cross-species transplantation (xenotransplantation) has immense potential to solve the critical need for organs, tissues and cells for clinical transplantation. The increasing availability of genetically engineered pigs is enabling progress to be made in pig-to-nonhuman primate experimental models. Potent pharmacologic immunosuppressive regimens have largely prevented T-cell rejection and a T-cell-dependent elicited antibody response. However, coagulation dysfunction between the pig and primate is proving to be a major problem, and this can result in life-threatening consumptive coagulopathy. This complication is unlikely to be overcome until pigs expressing a human ‘antithrombotic’ or ‘anticoagulant’ gene, such as thrombomodulin, tissue factor pathway inhibitor or CD39, become available. Progress in islet xenotransplantation has been more encouraging, and diabetes has been controlled in nonhuman primates for periods in excess of 6 months, although this has usually been achieved using immunosuppressive protocols that might not be clinically applicable. Further advances are required to overcome the remaining barriers.Keywords
This publication has 155 references indexed in Scilit:
- Pig Liver Xenotransplantation as a Bridge to Allotransplantation: Which Patients Might Benefit?Transplantation, 2009
- Suppressive Efficacy and Proliferative Capacity of Human Regulatory T Cells in Allogeneic and Xenogeneic ResponsesTransplantation, 2008
- Coagulation dysregulation as a barrier to xenotransplantation in the primateTransplant Immunology, 2008
- Expression of Tissue Factor and Initiation of Clotting by Human Platelets and Monocytes After Incubation With Porcine Endothelial CellsTransplantation, 2008
- Pig–to–Non-human Primate Heart Transplantation: Immunologic Progress Over 20 YearsThe Journal of Heart and Lung Transplantation, 2007
- Role for CD47-SIRPα signaling in xenograft rejection by macrophagesProceedings of the National Academy of Sciences, 2007
- Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal?1?3Gal), blood group H determinant andN-glycolylneuraminic acidGlycoconjugate Journal, 1996
- Distribution of the major xenoantigen (gal(α1–3)gal) for pig to human xenograftsTransplant Immunology, 1994
- Genetically engineered pigsThe Lancet, 1993
- Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in manTransplant Immunology, 1993